Genomic DNA regulatory elements controlling Zinc finger protein 410 expression (ZNF410 regulatory elements)

Genomic DNA regulatory elements controlling Zinc finger protein 410 (ZNF410) expression are the cis-acting DNA sequences, such as enhancers and promoters, that dictate the transcriptional activity of the ZNF410 gene. ZNF410 is a specialized transcription factor that has recently been identified as a master regulator of fetal hemoglobin (HbF) silencing in adult erythroid cells. It achieves this by acting as a singular activator of CHD4, a core component of the NuRD (Nucleosome Remodeling and Deacetylase) complex, which directly represses the fetal globin genes (HBG1 and HBG2). Because ZNF410 is highly selective for CHD4 and appears to be dispensable for normal hematopoiesis and erythroid maturation, its regulatory elements represent a high-priority therapeutic target for treating hemoglobinopathies. By using gene-editing technologies like CRISPR/Cas9 to disrupt these elements, researchers aim to downregulate ZNF410 expression, which in turn reduces CHD4 levels and triggers the reactivation of HbF production. This strategy offers a potentially wider therapeutic index compared to targeting more pleiotropic factors like BCL11A, as it avoids the systemic toxicities associated with broader transcriptional disruption.

Other names

ZNF410 enhancersZNF410 promoterZNF410 cis-regulatory elementsAPA-1 regulatory elementsZinc finger protein 410 regulatory elements

Therapeutic disruption or modulation of these regulatory elements (e.g., via CRISPR-Cas9) leads to the downregulation of ZNF410 expression. Reduced ZNF410 levels result in decreased activation of the CHD4 gene, a key component of the NuRD repressor complex. This reduction in CHD4/NuRD activity allows for the reactivation of fetal hemoglobin (HbF) production, which can compensate for defective adult hemoglobin in patients with sickle cell disease or beta-thalassemia.